SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Metropolis Healthcare shines on getting nod to acquire 100% stake in Core Diagnostics

10 Dec 2024 Evaluate

Metropolis Healthcare is currently trading at Rs. 2208.85, up by 21.85 points or 1.00% from its previous closing of Rs. 2187.00 on the BSE.

The scrip opened at Rs. 2230.75 and has touched a high and low of Rs. 2250.00 and Rs. 2205.00 respectively. So far 8334 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2306.85 on 10-Oct-2024 and a 52 week low of Rs. 1450.05 on 12-Jan-2024.

Last one week high and low of the scrip stood at Rs. 2250.00 and Rs. 2065.80 respectively. The current market cap of the company is Rs. 11414.93 crore.

The promoters holding in the company stood at 49.43%, while Institutions and Non-Institutions held 46.58% and 3.99% respectively.

Metropolis Healthcare has received approval for acquisition of the 100% stake in Core Diagnostics, India, from its existing shareholder, Core Diagnostics (Mauritius) for a total purchase consideration of Rs 246.83 crore to be discharged partly by cash and partly by way of preferential issue and allotment of equity shares of the Company (by way of share swap) subject to approval of the shareholders of the Company. Pursuant to the completion of acquisition, Core Diagnostics will become a wholly owned subsidiary of the Company. The Board of Directors of the Company at its meeting held on December 09, 2024 has inter-alia, approved the same. 

Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services.


Metropolis Health. Share Price

470.80 -1.75 (-0.37%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×